Braveheart Bio, Inc. BRVE
19.27 USD +0.74 (+3.99%)
Regular-session close
19.27 0.00 0.00%
After hours · Nov 19, 4:00 PM ET
18.24 Day range 19.50
17.42 52-week range 30.00
- YTD
- -35.34%
- 1 year
- -35.34%
Held by funds
37 US ETFs and mutual funds hold BRVE · largest positions
- FSPHX 0.31% of fund $20.92M
- FGCKX 0.02% of fund $15.75M
- VTI 0.00% of fund $14.49M
- FIDGX 0.13% of fund $11.87M
- FBIOX 0.19% of fund $11.30M
- FHCIX 0.30% of fund $10.10M
- FBTTX 0.30% of fund $7.06M
- VXF 0.01% of fund $5.08M
- FDSSX 0.03% of fund $3.56M
- FDSCX 0.04% of fund $2.91M
- SHSSX 0.04% of fund $2.36M
- SCHA 0.01% of fund $2.23M
- FSMAX 0.01% of fund $2.09M
- BDMIX 0.01% of fund $1.53M
- FTASX 0.01% of fund $1.23M
- FFTMX 0.01% of fund $1.19M
- FEYTX 0.02% of fund $1.18M
- FSMO 0.08% of fund $1.16M
- FSKAX 0.00% of fund $910.29K
- FNCMX 0.00% of fund $697.04K
Ownership
Held by insiders 62.36%
Held by institutions 83.18%
Float held by institutions 220.96%
Institutions 72
Top institutional holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| FCPM III Services B.V. | 24.29% | 21,826,024 | 420.59M | Sep 29, 2026 |
| Orbimed Advisors LLC. | 13.55% | 12,175,159 | 234.62M | Sep 29, 2026 |
| a16z Capital Management, L.L.C. | 11.39% | 10,232,420 | 197.18M | Sep 29, 2026 |
| FMR, LLC | 8.44% | 7,585,769 | 146.18M | Sep 29, 2026 |
| Frazier Life Sciences Management, L.P. | 5.86% | 5,267,321 | 101.50M | Sep 29, 2026 |
| Enavate Sciences Gp, LLC | 4.09% | 3,674,656 | 70.81M | Sep 29, 2026 |
Top mutual fund holders
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| SmallCap World Fund Inc | 2.53% | 2,273,151 | 43.80M | Sep 29, 2026 |
| Fidelity Select Portfolios-Select Health Care Portfolio | 1.15% | 1,035,862 | 19.96M | Sep 29, 2026 |
| Fidelity Mt. Vernon Street Trust-Fidelity Growth Company Fund | 0.87% | 779,600 | 15.02M | Sep 29, 2026 |
| Fidelity Rutland Square TRT II-Strategic Advisers Fidelity U.S. Total | 0.80% | 718,200 | 13.84M | Sep 29, 2026 |
| Fidelity Select Portfolios-Select Biotechnology Portfolio | 0.62% | 559,564 | 10.78M | Sep 29, 2026 |
| Fidelity Advisor Series VII-Fidelity Advisor Health Care Fund | 0.56% | 500,000 | 9.63M | Sep 29, 2026 |
Included in Plus and up
Sign in to see Institutional ownership
How much funds own from their 13F filings, quarter by quarter, and the largest holders.
Free with an account
Sign in to see Insider activity
Two years of insider buying and selling by month, marked on the price.
Included in Plus and up
Sign in to see Congress trading
Every stock trade disclosed by members of the US Senate and House.
Free with an account
Sign in to see CEO compensation
What the chief executive was paid each year, by salary, bonus and stock, beside the company's earnings.
Free with an account
Sign in to see Board of directors
Who sits on the board, who chairs it, and how long each director has served.
Insiders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CHIMOVITS EREZ | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Aug 6, 2026 | 0 |
| JIANGSU HENGRUI PHARMACEUTICALS CO. LTD. | Beneficial Owner of more than 10% of a Class of Security | Conversion of Exercise of derivative security | Aug 6, 2026 | 7,420,090 |
| LUBNER DAVID CHARLES | Director | Purchase | Aug 6, 2026 | 55,555 |
| MURDOCH TRAVIS | Chief Executive Officer | Purchase | Aug 6, 2026 | 8,333,640 |
| RICKEY JAMES PAUL | Chief Financial Officer | Purchase | Aug 6, 2026 | 703,575 |
| VIEHBACHER CHRISTOPHER | Director | Purchase | Aug 6, 2026 | 759,857 |
